Reason: MRNA's within-cycle move has extended further still - 1-year change now +499.46% (was +463.91%), 1-year alpha +480.81, 30D +158.71% - still the sharpest number on the desk, and the magnitude beyond the previously-noted litigation settlement remains unaccounted for; no fresher news receipt was pulled this cycle. AMGN's 1-year change and alpha both improved further (+56.1%/+37.45%, up from +51.4%/+31.53%) near a fresh high. TMO and VRTX both cooled slightly on the short window but remain golden-crossed, above their 200-day, with positive 1-year alpha.

Tape Read

$MRNA remains the most extreme move on the desk: price $145.55, RSI 63.2 (roughly unchanged from 63.5), golden-cross, regime pullback, thesis unrated, 1D -2.23%, 7D +5.5% (was -4.89%), 30D +158.71% (up from +153.24%), 3M +206.81%, 1-year change +499.46% (up from +463.91%), 165.5% above its 200-day average (vs 200-day, up from 166.6%), 1-year alpha +480.81 — still -17.61% off its 52-week high (improved from -21.89%) despite the size of the move. The most recent news receipt on file (fetched 2026-08-28, ok: true, not stale) still tops with "Moderna shares rise after settling COVID-19 vaccine technology legal battle" — a plausible partial driver noted last cycle, but no fresher receipt was pulled this session and a single litigation settlement still does not explain a 1-year change in the hundreds of percent; research/stock-events/ continues to show only Q1 2026 results (2026-07-31) and a scheduled Q3 print (2026-11-05), neither landing on this window. The magnitude beyond the noted receipt remains unaccounted for. $AMGN: price $437.23, RSI 62.5, golden-cross, regime uptrend, thesis unrated, 1D -1.55%, 7D +1.11%, 30D +7.84%, -2.19% off its 52-week high (improved from -3.27%), 1-year change +56.1% (up from +51.4%), vs 200-day +23.4% (up from +21.5%), 1-year alpha +37.45 (up from +31.53) — genuinely intact strength, extending near a fresh high. $TMO: price $613.78, RSI 57.4, golden-cross, regime uptrend, thesis intact, 1D -0.75%, 7D -1.32%, 30D +6.22% (down slightly from +7.93%), -5.13% off its high (slightly worse than -3.84%), 1-year change +25.39% (down slightly from +27.04%), 1-year alpha +6.74 (down slightly from +7.17%) — steady, cooling modestly. $VRTX: price $546.12, RSI 59.4, golden-cross, regime uptrend (from breakout), thesis unrated, 1D -2.12%, 7D +0.83%, 30D +12.64%, -2.52% off its high (unchanged), 1-year change +37.59% (roughly flat vs +38.17%), 1-year alpha +18.93 (roughly flat). Source: full-scan pre-computed summaries as of the 2026-09-04 close — biotech ($MRNA, $VRTX, $TMO) and biotech-scan ($AMGN, tracked outside the core biotech watchlist); news receipt latest (last fetched 2026-08-28, not re-pulled this cycle).

• $MRNA — WATCH: 1D -2.23%, 30D +158.71%, 1-year change +499.46% — the desk's sharpest print, larger than last cycle's; the litigation-settlement receipt on file is unchanged and still does not account for the full magnitude.
• $AMGN — PROMOTE: RSI 62.5, golden-cross, regime uptrend, -2.19% off its 52-week high, 1-year change +56.1%, 1-year alpha +37.45 — genuinely intact and strengthening.
• $TMO — WATCH: golden-cross, regime uptrend, thesis intact, 1-year change +25.39%, 1-year alpha +6.74 — steady, cooling slightly.
• $VRTX — WATCH: golden-cross, regime uptrend, 1-year change +37.59%, 1-year alpha +18.93 — roughly flat vs last cycle.

Lead pick: $MRNA's move is still the largest number on the desk this cycle and has grown further since last week; no fresh news receipt was pulled beyond the previously-noted litigation-settlement item, so the size and speed still argue for treating it as an outlier requiring verification rather than a clean promote. $AMGN is the cleanest confirmed leader: near a fresh high, with the year (+56.1%) and alpha (+37.45) both improving further.

Sources

• Tape data (price/RSI/SMA/returns/1-year change/1-year alpha): full-scan pre-computed summaries as of the 2026-09-04 close — biotech ($MRNA, $VRTX, $TMO) and biotech-scan ($AMGN, tracked outside the core biotech watchlist).
• News check (MRNA move): latest (fetched 2026-08-28, ok: true, not stale as of that pull — not re-fetched this cycle) and research/stock-events/ (no event dated to this window).